Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.39 - $2.83 $286,806 - $2.08 Million
735,400 Added 81.59%
1,636,700 $736,000
Q2 2023

Aug 14, 2023

BUY
$1.51 - $2.63 $149,641 - $260,633
99,100 Added 12.35%
901,300 $1.36 Million
Q1 2023

May 15, 2023

SELL
$2.1 - $4.11 $751,590 - $1.47 Million
-357,900 Reduced 30.85%
802,200 $1.8 Million
Q4 2022

Feb 14, 2023

BUY
$3.23 - $6.83 $652,783 - $1.38 Million
202,100 Added 21.1%
1,160,100 $3.87 Million
Q3 2022

Nov 14, 2022

BUY
$4.95 - $11.08 $1.9 Million - $4.26 Million
384,200 Added 66.96%
958,000 $4.74 Million

Others Institutions Holding RAD

About RITE AID CORP


  • Ticker RAD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 56,535,400
  • Market Cap $9.61M
  • Description
  • Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter m...
More about RAD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.